Despite these limitations, on balance our data demonstrate several causative relationships between ROS, Tregs, and tumor burden, including a first described causal relationship between TXNRD1 inhibitors like auranofin and Treg expansion. This evidence concerns the gene TXNRD1 and neoplasm.